Comorbid Diabetes and Severe Mental Illness: Outcomes in an Integrated Health Care Delivery System.
diabetes
health outcomes
healthcare delivery system
severe mental illness
Journal
Journal of general internal medicine
ISSN: 1525-1497
Titre abrégé: J Gen Intern Med
Pays: United States
ID NLM: 8605834
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
30
10
2018
accepted:
25
09
2019
revised:
02
05
2019
pubmed:
11
11
2019
medline:
15
5
2021
entrez:
10
11
2019
Statut:
ppublish
Résumé
Diabetes prevalence is twice as high among people with severe mental illness (SMI) when compared to the general population. Despite high prevalence, care outcomes are not well understood. To compare diabetes health outcomes received by people with and without comorbid SMI, and to understand demographic factors associated with poor diabetes control among those with SMI. Retrospective cohort study PARTICIPANTS: 269,243 adults with diabetes MAIN MEASURES: Primary outcomes included optimal glycemic control (A1c < 7) or poor diabetes control (A1c > 9) in 2014. Secondary outcomes included control of other cardiometabolic risk factors (hypertension, dyslipidemia, smoking) and recommended diabetes monitoring. Among this cohort, people with SMI (N = 4,399), compared to those without SMI (N = 264,844), were more likely to have optimal glycemic control, adjusting for various covariates (adjusted relative risk (aRR) 1.25, 95% CI 1.21-1.28, p < .001) and less likely to have poor control (aRR 0.92, 95% CI 0.87-0.98, p = 0.012). Better blood pressure and lipid control was more prevalent among people with SMI when compared to those without SMI (aRR 1.03; 95% CI 1.02-1.05, p < .001; aRR 1.02; 95% CI 1.00-1.05, p = 0.044, respectively). No differences were observed in recommended A1c or LDL testing, but people with SMI were more likely to have blood pressure checked (aRR 1.02, 95% CI 1.02-1.03, p < .001) and less likely to receive retinopathy screening (aRR 0.80, 95% CI 0.71-0.91, p < .001) than those without SMI. Among people with diabetes and comorbid SMI, younger adults and Hispanics were more likely to have poor diabetes control. Adults with diabetes and comorbid SMI had better cardiometabolic control than people with diabetes who did not have SMI, despite lower rates of retinopathy screening. Among those with comorbid SMI, younger adults and Hispanics were more vulnerable to poor A1c control.
Sections du résumé
BACKGROUND
Diabetes prevalence is twice as high among people with severe mental illness (SMI) when compared to the general population. Despite high prevalence, care outcomes are not well understood.
OBJECTIVE
To compare diabetes health outcomes received by people with and without comorbid SMI, and to understand demographic factors associated with poor diabetes control among those with SMI.
DESIGN
Retrospective cohort study PARTICIPANTS: 269,243 adults with diabetes MAIN MEASURES: Primary outcomes included optimal glycemic control (A1c < 7) or poor diabetes control (A1c > 9) in 2014. Secondary outcomes included control of other cardiometabolic risk factors (hypertension, dyslipidemia, smoking) and recommended diabetes monitoring.
KEY RESULTS
Among this cohort, people with SMI (N = 4,399), compared to those without SMI (N = 264,844), were more likely to have optimal glycemic control, adjusting for various covariates (adjusted relative risk (aRR) 1.25, 95% CI 1.21-1.28, p < .001) and less likely to have poor control (aRR 0.92, 95% CI 0.87-0.98, p = 0.012). Better blood pressure and lipid control was more prevalent among people with SMI when compared to those without SMI (aRR 1.03; 95% CI 1.02-1.05, p < .001; aRR 1.02; 95% CI 1.00-1.05, p = 0.044, respectively). No differences were observed in recommended A1c or LDL testing, but people with SMI were more likely to have blood pressure checked (aRR 1.02, 95% CI 1.02-1.03, p < .001) and less likely to receive retinopathy screening (aRR 0.80, 95% CI 0.71-0.91, p < .001) than those without SMI. Among people with diabetes and comorbid SMI, younger adults and Hispanics were more likely to have poor diabetes control.
CONCLUSIONS
Adults with diabetes and comorbid SMI had better cardiometabolic control than people with diabetes who did not have SMI, despite lower rates of retinopathy screening. Among those with comorbid SMI, younger adults and Hispanics were more vulnerable to poor A1c control.
Identifiants
pubmed: 31705468
doi: 10.1007/s11606-019-05489-3
pii: 10.1007/s11606-019-05489-3
pmc: PMC6957587
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
160-166Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK092924
Pays : United States
Organisme : NIDDK NIH HHS
ID : R03 DK101857
Pays : United States
Références
Arch Intern Med. 2005 Dec 12-26;165(22):2631-8
pubmed: 16344421
Am J Manag Care. 2009 May;15(5):295-301
pubmed: 19435397
Diabetes Care. 2018 Jul;41(7):e119-e120
pubmed: 29898903
J Gen Intern Med. 2016 Sep;31(9):1083-91
pubmed: 27149967
Psychiatry Res. 2011 Jun 30;188(1):109-14
pubmed: 21459458
Psychiatry Res. 2017 Apr;250:17-24
pubmed: 28135643
Psychiatr Serv. 2006 Jul;57(7):1016-21
pubmed: 16816287
BMC Psychiatry. 2008 Sep 25;8:84
pubmed: 18817565
J Nerv Ment Dis. 2006 Jun;194(6):404-10
pubmed: 16772856
Diabetes Care. 2014 Aug;37(8):2261-7
pubmed: 24879839
Health Serv Res. 2008 Apr;43(2):496-514
pubmed: 18370965
J Gen Intern Med. 2011 Feb;26(2):170-6
pubmed: 20878497
Psychiatr Serv. 2018 Jun 1;69(6):726-728
pubmed: 29446331
JAMA Intern Med. 2015 Dec;175(12):1977-9
pubmed: 26551047
J Gen Intern Med. 2018 Jan;33(1):79-86
pubmed: 29090381
JAMA. 2000 Jan 26;283(4):506-11
pubmed: 10659877
Diabetes Care. 2005 Jul;28(7):1769-78
pubmed: 15983333
Psychiatr Serv. 2009 Dec;60(12):1595-602
pubmed: 19952148
Arch Gen Psychiatry. 2010 Jan;67(1):17-24
pubmed: 20048219
CNS Drugs. 2005;19 Suppl 1:1-93
pubmed: 15998156
Am J Psychiatry. 2017 Jul 1;174(7):686-694
pubmed: 28103712
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
Schizophr Bull. 2010 Mar;36(2):428-35
pubmed: 18718883
N Engl J Med. 2010 Feb 18;362(7):590-9
pubmed: 20089957
Prev Chronic Dis. 2006 Apr;3(2):A42
pubmed: 16539783
Diabetes Obes Metab. 2018 Aug;20(8):1809-1811
pubmed: 29658190
Intern Med J. 2018 Jun;48(6):728-731
pubmed: 29898267
Gen Hosp Psychiatry. 2015 Mar-Apr;37(2):101-8
pubmed: 25578791